Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ATNMCompany Name
ACTINIUM PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NYSEMKTACTINIUM PHARMACEUTICALS INC - Interest Expense Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ATNM - Int. Exp. % Historical data
| Date | Interest Expense | Interest Expense Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 0 | 0% | $ 0 |
| 3/31/2025 | $ 0 | 0% | $ 0 |
| 12/31/2024 | $ 0 | 0% | $ 0 |
| 9/30/2024 | $ 0 | 0% | $ 81K |
| 6/30/2024 | $ 0 | 0% | $ 81K |
| 3/31/2024 | $ 0 | 0% | $ 81K |
| 12/31/2023 | $ 0 | 0% | $ 81K |
| 9/30/2023 | $ 0 | 0% | $ 0 |
| 6/30/2023 | $ 0 | 0% | $ 45K |
| 3/31/2023 | $ 0 | 0% | $ 90K |
Key Performance Insights, Last 5 Years
- ACTINIUM PHARMACEUTICALS INC's latest trailing twelve months (TTM) Int. Exp. % stands at 0%.
- Over the past 5 years, ACTINIUM PHARMACEUTICALS INC's average Int. Exp. % has been 0%.
- The median Int. Exp. % for ACTINIUM PHARMACEUTICALS INC during this period was 0%
- ACTINIUM PHARMACEUTICALS INC reached its highest Int. Exp. % over the past 5 years at 0%.
- The lowest Int. Exp. % recorded by ACTINIUM PHARMACEUTICALS INC in the same timeframe 0%
Similar metrics to Revenues:
- Interest Expense - [Income Statement] Interest expense is the cost incurred by a business for borrowing funds.
- Research and Development Margin - [Calculation] The company’s research and development expenses [RnD] expressed as a percentage of [Revenue].
- Stock Based Compensation Margin - [Calculation] The company’s stock-based compensation [SbComp] expressed as a percentage of [Revenue].
- Operating Cash Flow Margin - [Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
- Depreciation and Amortization Margin - [Calculation] The company’s deprecation and amortization [DepAmor] expressed as a percentage of [Revenue].
Definition of Interest Expense Margin
[Calculation] The company’s interest expenses [IntExp] expressed as a percentage of [Revenue].Int. Exp. / Revenues
(=) Int. Exp. % Int. Exp. % for ACTINIUM PHARMACEUTICALS INC is calculated as follows: Int. Exp. [ $ 0 ] / Revenues [ $ 0 ]
(=) Int. Exp. % [ 0% ] ATNM - Interest Expense Margin, Last 5 years
0%
Minimum
Mar 31, 2021
0%
Maximum
Mar 31, 2021
0%
Average
0%
Median
Int. Exp. % Benchmark AnalysisMarket
The chart above depicts the distribution of Int. Exp. % for companies in the Total Stock Market. The average Int. Exp. % of the companies is 1.63% with a standard deviation of 2.2%.
The following table provides additional summary stats:
Int. Exp. % in the Market:
| filtered constituents | 3.15K |
|---|---|
| min | -4.94% |
| max | 8.49% |
| average | 1.63% |
| median | 0.79% |
| std | 2.2% |